Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $48.66 and last traded at $48.61, with a volume of 114786 shares changing hands. The stock had previously closed at $46.70.
Analysts Set New Price Targets
A number of analysts have recently commented on the company. UBS Group downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday. BNP Paribas cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
View Our Latest Analysis on SDZNY
Sandoz Group Stock Performance
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
See Also
- Five stocks we like better than Sandoz Group
- Breakout Stocks: What They Are and How to Identify Them
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Are Treasury Bonds?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Ride Out The Recession With These Dividend Kings
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
